Status:
UNKNOWN
A Prospective Study of Treating Duodenal Papillary Sphincter in Different Ways During ERCP
Lead Sponsor:
Zhujiang Hospital
Collaborating Sponsors:
Nanfang Hospital, Southern Medical University
Conditions:
ERCP
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed to remove bile duct stones.Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilation (EPBD), and endoscopic sph...
Detailed Description
Investigators first divided the patients with different sizes of common bile duct stones into two groups. The bile duct stone diameter of group A is less than 1.0cm while group B is more than 1.0cm an...
Eligibility Criteria
Inclusion
- Age 20-80 years old
- CT or MRCP diagnose the patients with Common bile duct stones
- The diameter of the stone is less than or equal to 1.5cm
- Patients with the indications for ERCP
- Patients and their families agree to participate in the trial
Exclusion
- Stones are too large (\> 1.5cm)
- A history of gastrointestinal surgery
- ERCP and EST or EPBD surgery history
- Patients generally poor, total bilirubin\> 200umol / L or PT time extension\> 3s
- Patients with mental illness or other serious heart and lung disease
Key Trial Info
Start Date :
July 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT03416205
Start Date
July 20 2017
End Date
September 1 2021
Last Update
March 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhujiang Hospital
Guangzhou, Guangdong, China, 510282